Working Paper of Public Health Volume 2012 - Azienda Ospedaliera ...

More documents

Recommendations

Info

Azienda Ospedaliera Nazionale“SS. Antonio e Biagio e Cesare Arrigo”Working Paper of Public Healthnr. 12/2012[83] S. Fedele, N. Kumar, R. Davies, J. Fiske, S. Greening, S. Porter, “Dental managementof patients at risk of osteochemonecrosis of the jaws: a critical review,” Oral Dis., vol. 15,no. 8, pp. 527-537, 2009.[84] A. Borgioli, C. Viviani, M. Duvina, L. Brancato, G. Spinelli, M.L. Brandi, P. Tonelli,“Biphosphonates-related osteonecrosis of the jaw: Clinical and physiopathologicalconsiderations,” Clin Risk Manag., vol. 5, no. 1, pp. 217-227, 2009.[85] C.I. Ripamonti, M. Maniezzo, T. Campa, E. Fagnoni, C. Brunelli, G. Saibene, C.Bareggi, L. Ascani, E. Cislaghi, “Decreased occurrence of osteonecrosis of the jaw afterimplementation of dental preventive measures in solid tumour patients with bone metastasestreated with bisphosphonates. The experience of the National Cancer Institute of Milan,” AnnOncol., vol. 20, no. 1, pp. 137-145, 2009.[86] A.M. Vandone, M. Donadio, M. Mozzati, M. Ardine, M.A. Polimeni, S. Beatrice, L.Ciuffreda, M. Scoletta, “Impact of dental care in the prevention of bisphosphonate-associatedosteonecrosis of the jaw: a single-center clinical experience,” Ann Oncol., 2011.[87]G. Lodi, A. Sardella, A. Salis, F. Demarosi, M. Tarozzi, A. Carrassi, “Tooth extraction inpatients taking intravenous bisphosphonates: a preventive protocol and case series,” J OralMaxillofac Surg., vol. 68, no. 1, pp. 107-110, 2010.[88] M. Scoletta, P.G. Arduino, R. Pol, V. Arata, S. Silvestri, A. Chiecchio, M. Mozzati,“Initial experience on the outcome of teeth extractions in intravenous bisphosphonate-treatedpatients: a cautionary report,” J Oral Maxillofac Surg., vol. 69, no. 2, pp. 456-462, 2010.[89] S. Ferlito, S. Puzzo, C. Liardo, “Preventive protocol for tooth extractions in patientstreated with zoledronate: a case series,” J Oral Maxillofac Surg., vol. 69, no. 6, pp. 1-4, 2011.[90] F. Bertoldo, G. Bianchi, “[Comment on the article "Bisphosphonate-associatedosteonecrosis of the jaw in rheumatology: a systematic review" by Capsoni Franco],”Reumatismo, vol. 60, no. 3, pp. 234-235, 2008.[91] F. Bertoldo, F. Aging, “Bisphosphonates and osteonecrosis of the mandible/maxilla inosteoporosis: no reason to panic,” Clin Exp Res., vol.20, no.1, pp. 87-90, 2008.[92] G. Favia, G.P. Pilolli, E. Maiorano, “Histologic and histomorphometric features ofbisphosphonate-related osteonecrosis of the jaws: an analysis of 31 cases with confocal laserscanning microscopy,” Bone, vol. 45, no. 3, pp. 406-413, 2009.[93] G. Gasparini, G. Saponaro, F. Di Nardo, A. Moro, R. Boniello, D. Cervelli, T.M.Marianetti, G. Palazzoni, S. Pelo, “Clinical experience with spiramycin in bisphosphonate-18
Azienda Ospedaliera Nazionale“SS. Antonio e Biagio e Cesare Arrigo”Working Paper of Public Healthnr. 12/2012associated osteonecrosis of the jaw,” Int J Immunopathol Pharmacol., vol. 23, no. 2, pp. 619-626, 2010.[94] M. Manfredi, E. Merigo, R. Guidotti, M. Meleti, P. Vescovi, “Bisphosphonate-relatedosteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis,” Int J OralMaxillofac Surg., vol. 40, no. 3, pp. 277-284, 2011.[95] S. Otto, M.H. Abu-Id, S. Fedele, P.H. Warnke, S.T. Becker, A. Kolk, T. Mücke, G.Mast, R. Köhnke, E. Volkmer, F. Haasters, O. Lieger, T. Iizuka, S. Porter, G. Campisi, G.Colella, O. Ploder, A. Neff, J. Wiltfang, M. Ehrenfeld, T. Kreusch, K.D. Wolff, S.R.Stürzenbaum, M. Schieker, C. Pautke, “Osteoporosis and bisphosphonates-relatedosteonecrosis of the jaw: not just a sporadic coincidence--a multi-centre study,” JCraniomaxillofac Surg., vol. 39, no. 4, pp. 272-277, 2010.[96] E. Serra, M. Paolantonio, G. Spoto, F. Mastrangelo, S. Tetè, M. Dolci“Bevacizumabrelatedosteneocrosis of the jaw,” Int J Immunopathol Pharmacol.,vol. 22, no. 4, pp. 1121-1123, 2009.[97] A. Brunello, G. Saia, A. Bedogni, D. Scaglione, U. Basso, “Worsening of osteonecrosisof the jaw during treatment with sunitinib in a patient with metastatic renal cell carcinoma,”Bone., vol. 44, no. 1, pp. 173-175, 2008.[98] V. Fusco, C. Porta, C. Paglino, A. Bedogni, G. Bettini, G. Saia, G. Campisi, M. Scoletta,A. Agrillo, A. Fasciolo “Osteonecrosis of the jaw (ONJ) in patients with renal cancer treatedwith bisphosphonates (BPs) and sunitinib or other targeted therapy (TT) agents: Amulticenter survey” . J Clin Oncol 29 (suppl): 2011 (suppl; abstr e15182)[99] R. Diego, O. D'Orto, D. Pagani, A. Agazzi, U. Marzano, G. Derada Troletti, W.Fontanella, L. Pignataro, “Bisphosphonate-associated osteonecrosis of the jaws: a therapeuticdilemma,” Oral Surg Oral Med Oral Pathol Oral Radiol Endod, vol. 103, no. 3, pp. 1-5,2007.[100] M. Scoletta, P.G. Arduino, P. Dalmasso, R. Broccoletti, M. Mozzati, “Treatmentoutcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospectivestudy,” Oral Surg Oral Med Oral Pathol Oral Radiol Endod., vol. 110, no. 1, pp. 46-53,2010.[101] P. Vescovi, S. Nammour, “Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ)therapy. A critical review,” Minerva Stomatol., vol. 59, no. 4, pp. 181-203, 2010.19
Page 2 and 3:
La serie di Working Paper of Public
Page 4 and 5:
Azienda Ospedaliera Nazionale“SS.
Page 6 and 7:
Page 8 and 9:
Page 10 and 11:
Page 12 and 13:
Page 14 and 15:
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Azienda Ospedaliera NazionaleSS. An
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87: Azienda Ospedaliera Nazionale“SS.
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
show all

Working Paper of Public Health Volume 2012 - Azienda Ospedaliera ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?